BOTTI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 9.020
AS - Asia 1.807
EU - Europa 1.394
Continente sconosciuto - Info sul continente non disponibili 247
SA - Sud America 240
AF - Africa 23
OC - Oceania 2
Totale 12.733
Nazione #
US - Stati Uniti d'America 8.954
SG - Singapore 706
CN - Cina 459
RU - Federazione Russa 234
IT - Italia 232
HK - Hong Kong 191
BR - Brasile 190
DE - Germania 180
IE - Irlanda 178
VN - Vietnam 168
UA - Ucraina 125
FR - Francia 117
SE - Svezia 77
BD - Bangladesh 66
GB - Regno Unito 63
KR - Corea 62
FI - Finlandia 53
PL - Polonia 49
JP - Giappone 46
CA - Canada 37
IN - India 24
NL - Olanda 17
AR - Argentina 16
BE - Belgio 16
MX - Messico 13
EC - Ecuador 11
ES - Italia 11
TR - Turchia 10
AT - Austria 9
IQ - Iraq 9
ID - Indonesia 8
UZ - Uzbekistan 7
CO - Colombia 6
MY - Malesia 6
CL - Cile 5
CZ - Repubblica Ceca 5
KG - Kirghizistan 5
PH - Filippine 5
VE - Venezuela 5
ZA - Sudafrica 5
DK - Danimarca 4
EU - Europa 4
JO - Giordania 4
KE - Kenya 4
PK - Pakistan 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
EG - Egitto 3
IL - Israele 3
LT - Lituania 3
MA - Marocco 3
MD - Moldavia 3
NP - Nepal 3
RO - Romania 3
RS - Serbia 3
TH - Thailandia 3
AZ - Azerbaigian 2
CR - Costa Rica 2
CY - Cipro 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
OM - Oman 2
PE - Perù 2
PT - Portogallo 2
SA - Arabia Saudita 2
TW - Taiwan 2
VC - Saint Vincent e Grenadine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CU - Cuba 1
GA - Gabon 1
GR - Grecia 1
IR - Iran 1
JM - Giamaica 1
LK - Sri Lanka 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 12.491
Città #
Wilmington 1.814
Houston 1.791
Woodbridge 1.411
Fairfield 489
Singapore 427
Chandler 422
Ashburn 308
Ann Arbor 295
Seattle 223
Beijing 207
San Jose 201
Hong Kong 185
Cambridge 176
Dublin 163
Medford 124
Dearborn 119
New York 111
Council Bluffs 96
Jacksonville 85
Rome 79
Santa Clara 73
The Dalles 68
Los Angeles 67
Lawrence 57
Hanoi 46
Lauterbourg 46
Ho Chi Minh City 43
Tokyo 42
Dallas 38
Moscow 38
Kraków 35
Helsinki 33
Buffalo 31
Munich 31
San Diego 31
São Paulo 29
Turin 20
Redwood City 17
Boardman 16
Guangzhou 16
Atlanta 15
Brussels 14
Milan 14
Shanghai 14
Chicago 12
Nuremberg 12
Zhengzhou 12
Da Nang 11
Nanjing 11
Kunming 10
Montreal 10
North Bergen 10
Orem 10
Warsaw 10
Denver 9
London 9
Manchester 9
Redondo Beach 9
Stockholm 9
Toronto 9
Brooklyn 8
Chennai 8
Mülheim 8
Columbus 7
Hefei 7
Jinan 7
Menlo Park 7
Norwalk 7
Poplar 7
San Francisco 7
Wuhan 7
Frankfurt am Main 6
Mountain View 6
Paris 6
Salt Lake City 6
San Mateo 6
Amsterdam 5
Boston 5
Curitiba 5
Falls Church 5
Hounslow 5
Nha Trang 5
Phoenix 5
Pune 5
Quito 5
Saint Louis 5
Utrecht 5
Vancouver 5
Amman 4
Ankara 4
Biên Hòa 4
Bắc Giang 4
Cagliari 4
Cangzhou 4
Casarile 4
Centrale 4
Chengdu 4
Dhaka 4
Espoo 4
Genoa 4
Totale 9.940
Nome #
Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo 570
Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis 530
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 509
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 498
IL-21 in the pathogenesis and treatment of skin diseases 448
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy 443
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target 441
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 418
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 409
Clindamycin versus clindamycin plus rifampicin in Hidradenitis Suppurativa treatment: clinical and ultrasound observations 397
Severe erytrodermic psoriasis in child twins: From clinical-pathological diagnosis to treatment of choice through genetic analyses: Two case reports 386
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 368
IL-21, a new player in pathogenesis of psoriasis 361
CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis 350
Effects of topical methotrexate loaded gold nanoparticle in cutaneous inflammatory mouse model 347
Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress 304
Long-term efficacy and safety of adalimumab on a severe case of Hidradenitis Suppurativa 291
Bowel-associated dermatosis arthritis syndrome and palisading neutrophilic granulomatous dermatitis as presentation of ulcerative colitis 262
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias 221
Cutaneous mastocytosis: a dermatological perspective 214
The combined role of clinical, reflectance confocal microscopy and dermoscopy applied to chronic discoid cutaneous lupus and subacutus lupus erythematosus: a case series and literature review 191
Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus 186
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations 185
Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers 177
Vulvar basal cell carcinoma, so rare? 163
Long-term treatment of plaque psoriasis with efalizumab: an Italian experience 162
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis 158
Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas 157
Allele-specific cytokine responses at the HLA-C locus: Implications for psoriasis 148
Genetic markers predictive of clinical response to biological drugs in psoriasis. 148
Nanomedicine in dermatology: Benefits and emerging applications 147
Dimethylfumarate efficacy and safety in palmoplantar psoriasis patient affected by hepatitis b and depression: A case report 146
Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab 144
Confocal, wide band spectral reflection microscope, and relevant spectral imaging method 143
Suicide risk and psychiatric comorbidity in patients with psoriasis. 141
Investigating the expression of the susceptibility allele HLA-Cw6 in psoriasis using a specific single chain fragment antibody 141
p53 promuove la progressione tumorale nelle cellule di melamona resistenti agli inibitori di BRAF 138
Genetic variations in IL6 and IL12B decreasing the risk for psoriasis 134
Patients with moderate to severe plaque psoriasis: One year after the European medicines agency recommendation of efalizumab suspension 132
IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis 131
Etanercept reverses downregulation of inhibitor of nuclear factor kappa-B kinase subunit alpha (IKKa) in psoriasis 130
HLA-Cw6 allele confers sensitivity to efalizumab treatment in psoriasis 126
Targeted therapy in nonmelanoma skin cancers 120
Assessing the expression of HLA-Cw6 using specific single chain antibody (scFv) 119
A Longitudinal Multiinstitutional Study of Vulvar Lichen Sclerosus: From Childhood to Perimenopause 110
Living matter observations with a novel hyperspectral supercontinuum confocal microscope for VIS to near-IR reflectance spectroscopy 107
TRIM8 and p53: Making the right decision 107
Programmed cell death in the skin 102
Human leucocyte antigen Cw6 predisposes to clinical response to the inlterleukin-12/23 blocker ustekinumab: results of long-term treatment 102
Label-free and non-invasive discrimination of HaCaT and melanoma cells in a co-culture model by hyperspectral confocal reflectance microscopy 101
Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis 96
Next generation sequencing technology to explore anti-inflammatory activity of IKKa in psoriasis 88
HLA-C*06:02 allele can influence clinical efficacy of certolizumab pegol? 87
Use of brodalumab for the treatment of chronic plaque psoriasis: a one-year real-life study in the Lazio region, Italy 79
Genetic variations in IL6 and IL12B as protective markers for psoriasis 76
TP63 and TP73 in cancer, an unresolved "family" puzzle of complexity, redundancy and hierarchy 71
Genetic variati ons in IL6 and IL12B as protecti ve markers for psoriasis Abstracts of the 2013 International Investigative Dermatology Meeting. May 8-11, 2013. Edinburgh, Scotland, United Kingdom 71
HLACw6 predisposes to clinical response to IL12/23 blocker ustekinumab: Results of short- and long-term treatment in anti-TNF naïve patients 71
Usefulness of topical imiquimod 3.75% in cytokeratin 7 positive extramammary paget disease of the vulva: towards personalized therapy 67
Potential role of HLA-Cw6 in clinical response to anti-tumour necrosis factor alpha and t-cell targeting agents in psoriasis patients 64
Totale 12.733
Categoria #
all - tutte 39.674
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.674


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022485 0 0 17 23 18 36 45 23 38 53 55 177
2022/2023845 91 81 73 108 56 210 57 43 82 5 31 8
2023/2024314 34 7 19 7 32 95 12 29 4 8 9 58
2024/20251.170 66 240 122 95 13 71 114 54 82 100 76 137
2025/20262.179 176 101 251 222 215 82 326 213 225 197 105 66
2026/2027263 110 119 34 0 0 0 0 0 0 0 0 0
Totale 12.733